|
JP5995728B2
(ja)
*
|
2010-03-04 |
2016-09-21 |
メルク・シャープ・エンド・ドーム・コーポレイション |
カテコールｏ−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用
|
|
GB201111704D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Novel compounds
|
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
|
JO3115B1
(ar)
|
2011-08-22 |
2017-09-20 |
Takeda Pharmaceuticals Co |
مركبات بيريدازينون واستخدامها كمثبطات daao
|
|
AP2014007637A0
(en)
|
2011-11-15 |
2014-05-31 |
Takeda Pharmaceutical |
Dihydroxy aromatic heterocyclic compound
|
|
TWI638802B
(zh)
|
2012-05-24 |
2018-10-21 |
芬蘭商奧利安公司 |
兒茶酚ｏ－甲基轉移酶活性抑制化合物
|
|
CN103845317B
(zh)
*
|
2012-11-28 |
2018-05-08 |
北京生命科学研究所 |
恩他卡朋在预防或治疗肥胖等代谢综合征中的应用
|
|
GB201222711D0
(en)
|
2012-12-17 |
2013-01-30 |
Takeda Pharmaceutical |
Novel compounds
|
|
EP2938600B1
(en)
|
2012-12-27 |
2017-01-25 |
F. Hoffmann-La Roche AG |
Comt inhibitors
|
|
US9695149B2
(en)
|
2013-03-15 |
2017-07-04 |
Janssen Pharmaceutica Nv |
1,2,6-substituted benzimidazoles as flap modulators
|
|
US9067917B2
(en)
|
2013-03-15 |
2015-06-30 |
Janssen Pharmaceutica Nv |
1,2,5-substituted benzimidazoles as FLAP modulators
|
|
CN103588702B
(zh)
*
|
2013-10-26 |
2016-01-06 |
浙江大学 |
N-取代苯基吡啶-4-酮衍生物及其制备和应用
|
|
US9988373B2
(en)
|
2013-12-26 |
2018-06-05 |
Shionogi & Co., Ltd. |
Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same
|
|
JP6858712B2
(ja)
|
2015-01-30 |
2021-04-14 |
リーバー インスティテュート フォー ブレイン ディベロップメントＬｉｅｂｅｒ Ｉｎｓｔｉｔｕｔｅ Ｆｏｒ Ｂｒａｉｎ Ｄｅｖｅｌｏｐｍｅｎｔ |
Ｃｏｍｔ阻害方法及び組成物
|
|
JP6358639B2
(ja)
|
2015-04-24 |
2018-07-18 |
塩野義製薬株式会社 |
６員複素環誘導体およびそれらを含有する医薬組成物
|
|
US20170107216A1
(en)
|
2015-10-19 |
2017-04-20 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
MD3377488T2
(ro)
|
2015-11-19 |
2023-02-28 |
Incyte Corp |
Compuși heterociclici ca imunomodulatori
|
|
WO2017091818A1
(en)
|
2015-11-25 |
2017-06-01 |
Lieber Institute For Brain Development |
Comt inhibiting methods and compositions
|
|
CN105481812B
(zh)
*
|
2015-11-30 |
2020-04-21 |
重庆天奕恒化科技有限公司 |
一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法
|
|
ES2916874T3
(es)
|
2015-12-17 |
2022-07-06 |
Incyte Corp |
Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
|
|
CA3009474A1
(en)
|
2015-12-22 |
2017-06-29 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
ES2906460T3
(es)
|
2016-05-06 |
2022-04-18 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
EP3464279B1
(en)
|
2016-05-26 |
2021-11-24 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
SG11201811414TA
(en)
|
2016-06-20 |
2019-01-30 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
US20180057486A1
(en)
|
2016-08-29 |
2018-03-01 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
EP3527568A4
(en)
|
2016-10-17 |
2020-03-18 |
Shionogi & Co., Ltd |
BICYCLIC NITROGENATED HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREFOR
|
|
EP4223369A1
(en)
|
2016-12-22 |
2023-08-09 |
Incyte Corporation |
Immunomodulator compounds and methods of use
|
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
WO2018119286A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
US10308644B2
(en)
|
2016-12-22 |
2019-06-04 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
JP6813665B2
(ja)
*
|
2017-03-31 |
2021-01-13 |
富士フイルム株式会社 |
４−ピリドン化合物またはその塩、それを含む医薬組成物および剤
|
|
CN108191746B
(zh)
*
|
2018-02-02 |
2020-06-16 |
暨南大学 |
一种羟基吡啶酮类化合物及其制备方法与应用
|
|
SMT202300065T1
(it)
|
2018-03-30 |
2023-05-12 |
Incyte Corp |
Composti eterociclici come immunomodulatori
|
|
CN112752756B
(zh)
|
2018-05-11 |
2024-06-25 |
因赛特公司 |
作为PD-L1免疫调节剂的四氢-咪唑并[4,5-c]吡啶衍生物
|
|
WO2020097396A1
(en)
|
2018-11-07 |
2020-05-14 |
Dana-Farber Cancer Institute, Inc. |
Benzimidazole derivatives and aza-benzimidazole derivatives as janus kinase 2 inhibitors and uses thereof
|
|
EP3876939A4
(en)
|
2018-11-07 |
2022-08-10 |
Dana-Farber Cancer Institute, Inc. |
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
|
|
US12509455B2
(en)
|
2018-11-07 |
2025-12-30 |
Dana-Farber Cancer Institute, Inc. |
Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereof
|
|
TW202115059A
(zh)
|
2019-08-09 |
2021-04-16 |
美商英塞特公司 |
Ｐｄ—１／ｐｄ—ｌ１抑制劑之鹽
|
|
JP7559059B2
(ja)
|
2019-09-30 |
2024-10-01 |
インサイト・コーポレイション |
免疫調節剤としてのピリド［３，２－ｄ］ピリミジン化合物
|
|
CA3156828A1
(en)
|
2019-10-03 |
2021-04-08 |
Dana-Farber Cancer Institute, Inc. |
Tricyclic kinase inhibitors and uses thereof
|
|
EP4058461A1
(en)
|
2019-11-11 |
2022-09-21 |
Incyte Corporation |
Salts and crystalline forms of a pd-1/pd-l1 inhibitor
|
|
CN111170936B
(zh)
|
2020-01-19 |
2021-01-01 |
杭州泽德医药科技有限公司 |
3,4-二羟基-n-(1’-苄基-2’-羟乙基)-2-甲基吡啶氯化物及制备和应用
|
|
TW202204350A
(zh)
|
2020-05-06 |
2022-02-01 |
美商雅捷可斯治療公司 |
作為ｊａｋ２抑制劑之６－雜芳基氧基苯并咪唑及氮雜苯并咪唑
|
|
KR102377058B1
(ko)
|
2020-11-04 |
2022-03-22 |
경북대학교 산학협력단 |
니아스텔라 코리엔시스에서 유래한 카테콜 o-메틸 트렌스퍼라제 및 이의 변이체
|
|
US11760756B2
(en)
|
2020-11-06 |
2023-09-19 |
Incyte Corporation |
Crystalline form of a PD-1/PD-L1 inhibitor
|
|
US11780836B2
(en)
|
2020-11-06 |
2023-10-10 |
Incyte Corporation |
Process of preparing a PD-1/PD-L1 inhibitor
|
|
IL302590A
(en)
|
2020-11-06 |
2023-07-01 |
Incyte Corp |
Process for preparing PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
|
|
EP4267574B1
(en)
|
2020-12-23 |
2025-04-23 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
WO2023004291A1
(en)
*
|
2021-07-19 |
2023-01-26 |
Baylor College Of Medicine |
Coronavirus main protease inhibitors and methods using same
|
|
CA3234638A1
(en)
|
2021-11-09 |
2023-05-19 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
US12162881B2
(en)
|
2021-11-09 |
2024-12-10 |
Ajax Therapeutics, Inc. |
Forms and compositions of inhibitors of JAK2
|
|
CN114716366B
(zh)
*
|
2022-04-13 |
2023-12-26 |
浙江大学 |
3-羟基吡啶-4-酮类衍生物及在抑制肾细胞铁死亡中的应用
|
|
CN116947812B
(zh)
*
|
2023-06-30 |
2025-09-02 |
南京红太阳医药研究院有限公司 |
一种艾司奥美拉唑镁降解杂质的制备方法
|
|
WO2025257687A1
(en)
*
|
2024-06-11 |
2025-12-18 |
Universidade Do Porto |
Hydroxypyridinone compounds as inhibitors of catechol-o-methyltransferase
|
|
CN118888845A
(zh)
*
|
2024-08-09 |
2024-11-01 |
惠州亿纬锂能股份有限公司 |
一种电解液与锂离子电池
|